Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 5/20 | 0.60 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.60 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.60 |
| ▸ | GSK3A | P49840 | 2/20 | 0.54 |
| ▸ | GSK3B | P49841 | 2/20 | 0.54 |
| ▸ | MAPK8 | P45983 | 8/20 | 0.53 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.53 |
| ▸ | MAPK9 | P45984 | 6/20 | 0.53 |
| ▸ | JUN | P05412 | 1/20 | 0.53 |
| ▸ | AXL | P30530 | 2/20 | 0.50 |
| ▸ | TYRO3 | Q06418 | 2/20 | 0.50 |
| ▸ | MERTK | Q12866 | 2/20 | 0.50 |
| ▸ | FLT3 | P36888 | 1/20 | 0.50 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.50 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.45 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6886667 | 1.00 | ADORA1 (0.60) | ADORA1ADORA2AADORA2BGSK3AGSK3B | |
| SCHEMBL6886647 | 0.91 | ADORA1 (0.51) | ADORA1ADORA2AADORA2BGSK3AGSK3B | |
| SCHEMBL6886534 | 0.85 | KDM4E (0.56) | ADORA1ADORA2AADORA2BAXLTYRO3 | |
| SCHEMBL6885645 | 0.84 | GRM5 (0.48) | ADORA1ADORA2AADORA2BMAPK10JUN | |
| SCHEMBL15915689 | 0.83 | ADORA1 (0.53) | ADORA1ADORA2AADORA2BGSK3AGSK3B | |
| SCHEMBL15917968 | 0.83 | ADORA1 (0.53) | ADORA1ADORA2AADORA2BGSK3AGSK3B | |
| SCHEMBL6887143 | 0.83 | KDM4E (0.59) | ADORA1AXLTYRO3MERTKFLT3 | |
| SCHEMBL6888147 | 0.83 | MERTK (0.46) | ADORA1ADORA2AADORA2BAXLTYRO3 | |
| SCHEMBL13062703 | 0.81 | HDAC1 (0.56) | ADORA1ADORA2AADORA2BMAPK8MKNK1 | |
| SCHEMBL6885119 | 0.81 | MAPK1 (0.62) | ADORA1MAPK8MAPK10MAPK9MKNK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389536-B2 | Positive allosteric modulators (PAM) | HOFFMANN-LA ROCHE INC. (US) | 2013-03-05 | — | — | US | disclosed |
| US-20110098313-A1 | POSITIVE ALLOSTERIC MODULATORS (PAM) | HOFFMANN-LA ROCHE, INC. | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098313-A1 | POSITIVE ALLOSTERIC MODULATORS (PAM) | GRM5, GRM1, GRM2 | ADORA1 161/4885ADORA2A 175/4885ADORA2B 509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.